Cơ Chế Tác Dụng :
BLX-883 is a form of alfa interferon developed by Biolex for the treatment of hepatitis viral C. Alfa interferon is used in the treatment of hepatitis C, hepatitis B, and multiple cancers and its worldwide sales currently exceed $3 billion.
BLX-883 is the first clinical-stage therapeutic candidate produced in Biolex' GMP facilities using its proprietary Lex System.
Chỉ Định :
Investigated for use/treatment in hepatitis (viral, C).